Navinci and Lumito Launch Pilot Project for Tissue Analysis Technologies
Navinci Diagnostics and Lumito AB have initiated a pilot project to combine their technologies for advanced tissue analysis. The project aims to enhance the sensitivity and information content of analyses.
Swedish companies Navinci Diagnostics AB and Lumito AB have commenced a joint pilot project to evaluate the integration of their respective technologies in advanced tissue analysis. The initiative seeks to combine Lumito's high-sensitivity image analysis platform with Navinci's in situ Proximity Ligation Technology (isPLA).
By merging the strengths of both technologies, the companies aim to enable more sensitive and information-rich analyses of tissue samples. This could provide researchers with enhanced tools for understanding biological processes and diagnosing diseases.
Initial results from the pilot project have shown promise. The collaboration focuses on the potential of advanced tissue analysis to offer deeper insights into the molecular functions within tissues.
Navinci's isPLA technology allows for the detection and quantification of specific proteins or other biomolecules directly within tissue sections. Lumito's platform provides robust tools for image analysis and data interpretation, complementing the information generated by Navinci's method.